AGP Picks
View all

European News Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European News Update.

Press releases published on June 15, 2026

NewcelX Publishes Peer-Reviewed Study Demonstrating Broad Therapeutic Potential of its Stem Cell Technology Platform
Weaviate Makes Engram Generally Available, Giving AI Agents Production-Grade Memory
250 Mio. Euro für KI-Infrastruktur: firstcolo startet Bau des Rechenzentrums FRA7 in Hessen
250 million euros for AI infrastructure: firstcolo breaks ground on FRA7 data center in Hesse
AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency
Quantum Cyber Executes Exclusive Quantum Antenna License Agreement, Positoning the Quantum Technology Layer at the Core of Its Defense Platform
ASML reports transactions under its current share buyback program
Aerska Strengthens Board with Appointments of Uli Stilz and Itziar Canamasas
Porosome Therapeutics Announces Global Drug Development Partnership with the Largest Governmental R&D Organization in India
Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.
Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update
Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™  in Patients with Osteoarthritis
Vaxart to Showcase Oral Vaccine Platform and Strategic Vision at BIO 2026 and Taiwan Biotech Forum
ASKO partners with the FIFA World Cup 2026™, honouring the dedication, time and dreams that define world-class performance
Two Weeks Left to Enter The Global Supply Chain Awards
Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company
HMNC Brain Health announces $50 million first closing of Series B financing and a strategic partnership with MEDICE
4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board
Surge Copper Announces Results of Berg Pre-Feasibility Study with After-Tax NPV8% of C$4.6 billion and 24% IRR
Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

European News Update

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.